Author

Elamine Zereg

Institute for Research in Immunology and CancerPrimary ORCID profile (0000-0002-6111-3805 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Elamine ZeregiD1 paper · Centre Hospitalier Universitaire de Nice

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Claude PerreaultiD· 1 shared Éric BonneiliD· 1 shared Franck TirodeiD· 1 shared Karl Grenier· 1 shared Laure VoisiniD· 1 shared Mathieu CourcellesiD· 1 shared Melania Gombos· 1 shared Pierre ThibaultiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Claude PerreaultORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Redundant roles of YES and SRC tyrosine kinases in driving malignant peripheral nerve sheath tumors

Elamine Zereg, Laure Voisin, Mathieu Courcelles, Sylvie Brochu, Melania Gombos, Éric Bonneil, Karl Grenier, Sungmi Jung, Claude Perreault, Franck Tirode, Pierre Thibault, Sylvain Meloche

This study identifies YES and SRC tyrosine kinases as redundant drivers of MPNST and shows their inhibition suppresses tumor growth and reactivates immune responses.

bioRxiv · Feb 20, 2026 · PreprintCancer Biology